External-use liquid medicine for treating gynecological inflammation

A technology for gynecological inflammation and liquid medicine, applied in the field of medicine, can solve the problems of liver and kidney function side effects, long treatment time, and serious harm to patients, and achieve the effect of increasing hormone levels and not easy to contaminate

Inactive Publication Date: 2019-03-29
宋永红
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, high-dose antibiotics are mainly used in the clinical treatment of gynecological inflammation. Although they have therapeutic effects, drug resistance will develop if the drugs are used for too long, and they will have certain side effects on liver and kidney functions, which will cause great harm to patients.
The existing traditional Chinese medicine or Chinese patent medicine takes a long time to treat, and the treatment effect is not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Take 8% Sophora flavescens extract, 6% Cork Phellodendron extract, 6% Dandelion extract, 5.2% Angelica sinensis extract, 3.3% seabuckthorn flavonoids, 0.5% rose flower extract, 0.5% probiotics, 1% domiphene, and the rest The amount is distilled water, and the above extracts are all extracted by the existing technology. One day after the above raw materials are mixed, 2.5% of Staphylococcus aureus enterotoxin B is added, and the external medicinal liquid is made by the existing technology.

Embodiment 2

[0029] Take 7% Sophora flavescens extract, 5% Phellodendron Phellodendron extract, 4% dandelion extract, 3.8% angelica extract, 2.5% seabuckthorn flavonoids, 0.5% rose extract, 0.05% probiotics, 0.5% domiphene, and the rest The amount is distilled water, and the above extracts are all extracted through the existing technology. One day after the above raw materials are mixed, 0.02% of Staphylococcus aureus enterotoxin A is added, and the external medicinal liquid is made through the existing technology.

Embodiment 3

[0031] Take 6% Sophora flavescens extract, 5% Phellodendron Phellodendron extract, 3% Dandelion extract, 4.9% Angelica sinensis extract, 3% seabuckthorn flavonoids, 0.8% rose flower extract, 0.5% probiotics, 1% domiphene, and the rest The amount is distilled water, and the above extracts are all extracted through the existing technology. One day after the above raw materials are mixed, 1% of Staphylococcus aureus enterotoxin B and 4% of Staphylococcus aureus enterotoxin subtype C are added. technology to make liquid medicine for external use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an external-use liquid medicine for treating gynecological inflammation. The external-use liquid medicine comprises the following raw materials of a radix sophorae flavescentis extract, a cortex phellodendri extract, a dandelion extract, a radix angelica sinensis extract, hippophae rhamnoides fruit flavone, a rose flower extract, egg white staphylococcus aureus enterotoxin, probiotics and domiphen bromide. The external-use liquid medicine disclosed by the invention is superhigh in effects of diminishing inflammation and killing bacteria; besides, through added super antigens, immunity can be rapidly regulated or activated by 2000-50000 times, body scent can be increased, hormone level can be balanced, the external-use liquid medicine can be quickly absorbed by skinand mucosa tissue, and the external-use liquid medicine can have the effects of repairing and treating on organs around the vagina.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to an external liquid medicine for treating gynecological inflammation. Background technique [0002] Gynecological inflammation refers to diseases caused by women's reproductive system infection, including female vulvitis, vaginitis, cervicitis, pelvic inflammatory disease, mycoplasma, chlamydia infection, etc. Gynecological inflammation has a high prevalence rate and a high recurrence rate, seriously affecting women's physical and mental health healthy. At present, high-dose antibiotics are mainly used in the clinical treatment of gynecological inflammation. Although they have therapeutic effects, drug resistance will develop if the drugs are used for too long, and they have certain side effects on liver and kidney functions, which is more harmful to patients. The existing traditional Chinese medicine or Chinese patent medicine has a long treatment time, and the therapeutic effect ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/085A61P15/00A61P31/04A61K36/756A61K31/14A61K31/722A61K35/741
CPCA61K9/0014A61K31/14A61K31/722A61K35/741A61K36/185A61K36/232A61K36/288A61K36/489A61K36/738A61K36/756A61K39/085A61P15/00A61P31/04A61K2300/00
Inventor 宋永红
Owner 宋永红
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products